NDAINTRAVENOUSSOLUTIONPriority Review
Approved
Apr 2019
Lifecycle
Peak
Competitive Pressure
0/100
Data completeness
2/8 — Basic
Priority Review
Drug data last refreshed 7h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Selenious acid is an intravenous micronutrient solution approved by the FDA in April 2019 as a single-entity formulation for parenteral nutrition support. It is an essential trace element used to prevent or treat selenium deficiency in patients requiring long-term parenteral nutrition. The drug works by providing bioavailable selenium, a critical cofactor for selenoprotein synthesis and antioxidant defense.
Peak14.9 years to LOE
As a peak-lifecycle micronutrient product with no direct competitors, this product likely operates within a small specialized team focused on hospital and parenteral nutrition channels.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on selenious acid offers a stable, niche career opportunity within Fresenius Kabi's hospital and critical care portfolio, with limited competitive disruption and strong patent protection through 2041. Roles on this product emphasize relationship-building with hospital pharmacies, dialysis centers, and nutrition support teams rather than high-velocity market competition.
Hospital Account Manager
Worked on SELENIOUS ACID at Fresenius Kabi? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.